The SMB group is composed of three companies collaborating on an exclusive basis, all dedicated to the research, development and production of innovative pharmaceutical products using advanced drug delivery solutions. We are committed to develop and provide innovative treatments for a wide range of therapeutic indication improving patient safety and compliance.